First Majestic Silver Surges on Q1 Beat and Asset Sales, But Thesis Hinges on Dividend and Capex Discipline

What happened

First Majestic Silver reported a strong Q1 with revenue up 95% YoY to $476.7M, free cash flow of $224M, and a record $1.13B treasury, while also divesting two non-core assets (San Martin and Del Toro) for up to $150M in total proceeds. These asset sales convert idle assets into liquidity, supporting capex for growth projects like Santo Niño and reinforcing the balance sheet. However, the DeepValue Master Report assigns a WAIT rating at $22.20, noting that the stock's elevated valuation (P/E 62.5) and high-beta silver exposure leave limited margin for error. The investment thesis depends critically on the company's ability to follow through on its new 2% of revenue dividend policy and keep 2026 capex within the $213–$236M guidance band over the next 6 months. While the Q1 results and asset sales are positive signals, they do not eliminate the key catalyst risk: the board's discretion on the dividend and the front-loaded spending on expansion projects.

Implication

The Q1 beat and asset sales provide a tactical tailwind, but they do not alter the primary thesis risks. First Majestic's valuation already discounts sustained silver prices and flawless execution on its dividend and capex plans. The asset sales bolster the balance sheet, which was already strong, but they also underscore management's focus on streamlining the portfolio. The real test comes in May and August 2026, when the first higher-rate dividends are due, and in H2 2026 when expansion projects are expected to complete. Until these milestones are met without deviation, the stock remains a high-beta silver proxy with limited company-specific safety, making the current price (near $22) unattractive for entry.

Thesis delta

The Q1 results and asset sales confirm operational momentum and financial flexibility, but they do not shift the core thesis: the stock's upside is conditional on dividend execution and capex containment. The positive news may narrow the downside tail risk given the larger liquidity buffer, but it does not expand the upside potential beyond the already-priced silver leverage. Therefore, the WAIT rating remains appropriate, with the re-assessment window opening after the May 2026 dividend announcement.